| Preview | Issue Date | Title / Name | Author(s) |
| Sep-2023 | Chronic lymphocytic leukaemia Australasian consensus practice statement | Anderson, Mary A.; Bennett, R.; Badoux, X.; Best, G.; Chia, N.; Cochrane, T.; Cull, G.; Crassini, K.; et. al; Crassini, Kyle | |
| Dec-2013 | Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial | Araujo, J. C.; Trudel, G. C.; Saad, F.; Armstrong, A. J.; Yu, E. Y.; Bellmunt, J.; Wilding, G.; McCaffrey, J.; Serrano, S. V.; Matveev, V. B.; Efstathiou, E.; Oudard, S.; Morris, M. J.; Goebell, P. J.; Heidenreich, A.; de Bono, J. S.; Begbie, S.; et. al; Begbie, Stephen | |
| Sep-2022 | Frail patients having vascular surgery during the early COVID-19 pandemic experienced high rates of adverse perioperative events and amputation | Aitken, S. J.; Allard, B.; Altaf, N.; Atkinson, N.; Aziz, O.; Battersby, R.; Benson, R.; Chambers, J. L.; Charlton, G.; Coleman, C.; Dawson, J. A.; Dean, A.; Dahl, B.; Fitridge, R.; Gan, J.; Hanna, J.; Hattam, A. T.; Hein, M.; Hon, K.; Khoo, S.; Kilby, J.; Kuang, B.; Leong, K. W.; Lim, E.; Liu, J. N.; McClure, D.; Mehta, S.; Moss, J.; Muller, J.; Musicki, K.; Nanhra, S.; Papanikolas, M. J.; Pineda, F. P.; Pond, F.; Ravintharan, N.; Richards, T.; Saeed, H.; Selvaraj, C. N; et. al; Chambers, Jennifer L.; Gan, John; Selvaraj, Christopher N. | |
| Aug-2023 | Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial | Antonarakis, E.; Park, S. H.; Goh, J. C.; Shin, S. J.; Lee, J. L.; Mehra, N.; Dermott, R.; Sala-Gonzalez, N.; Fong, P. C.; Greil, R.; Retz, M.; Sade, J. P.; Yanez, P.; Huang, Y.; Begbie, S. D.; et. al; Begbie, Stephen | |
